(Q39430931)

11 September 2017

1 reference

title

Psychotropic drugs in dermatology. A review and guidelines for use. (English)

1 reference

11 September 2017

Gupta MA

1

1 reference

11 September 2017

Gupta AK

series ordinal

2

1 reference

11 September 2017

Haberman HF

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 April 1986

1 reference

Journal of the American Academy of Dermatology

11 September 2017

published in

1 reference

11 September 2017

volume

14

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

633-645

1 reference

Psychosomatic concepts in dermatology. A dermatologist-psychoanalyst's viewpoint

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Dermatopsychosomatics: classification, physiology, and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Phrenotropic drugs in psychosomatic disorders (skin)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

A PSYCHOSOMATIC APPROACH TO THE MANAGEMENT OF RECALCITRANT DERMATOSES.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Emotion and skin--a double blind evaluation of psychotropic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

On the treatment of neurodermatitis with a monoamine oxidase inhibitor. The chemotherapy of psychosomatic illness through A-REM suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Clinical experience with pimozide: Emphasis on its use in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Itching: the pathophysiology of pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Monosymptomatic hypochondriacal syndromes in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Trazodone-induced hepatotoxicity and leukonychia.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Pigmentation Due to Phenothiazines in High and Prolonged Dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Chlorpromazine-induced lupuslike disease. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

In Vitro Studies on Longwave Ultraviolet Light-Dependent Reactions of the Skin Photosensitizer Chlorpromazine with Nucleic Acids, Purines and Pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Thiothixene drug sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Dermatologic manifestations of lithium: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

A Review and Controlled Study of Cutaneous Conditions associated with Lithium Carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Hair loss during lithium treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Hair loss following lithium therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Antinuclear antibodies in patients on lithium carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Lithium and lupuslike syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

1 reference

7 January 2021

Exfoliative dermatitis during lithium treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Adverse effects of antianxiety drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

The role of diazepam in skin hyperpigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

The fixed eruption. A possible hazard of modern drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Bullous eruption due to ethchlorvynol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Adverse Effects of Antipsychotic Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Tardive dyskinesia--reversible and persistent

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Adverse effects of antidepressant drugs. Part 2: 'Second generation' antidepressants and rational decision making in antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Current antidepressant drugs: their clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Psychotropic drugs in dermatologic practice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

Drug therapy. Current status of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2886%2970081-9

7 January 2021

10.1016/S0190-9622(86)70081-9

Identifiers

DOI

1 reference

11 September 2017

1 reference